Anatara Lifesciences Ltd (ANR)
Market Closed
ASX ASX Primary 10.19M Market Cap
13.27 P/E Ratio
- Div Yield
500,000 Volume
0 Eps
Want to track ANR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.01 |
| | | - | - |
ANR Earnings Reports FAQ
What is the earnings per share (EPS) for ANR?
The current EPS is 0.
What is the company's earnings growth rate?
Anatara Lifesciences Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-03-03, based on the ANR's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Anatara Lifesciences Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ANR at this time, as Anatara Lifesciences Ltd has no recent EPS data to calculate it.
